Search research articles
Contact Us
Filters
Showing results (251-260 of 305) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies
J Weber, J C Yang, S L Topalian, et al.
Journal of Environmental Radioactivity
|
May 22, 2012
Inorganic phosphorus fractionation and its translocation dynamics in a low-P soil
J C Yang, Z G Wang, J Zhou, et al.
The New England Journal of Medicine
|
August 30, 1990
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
S A Rosenberg, P Aebersold, K Cornetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Oncogene
|
March 26, 2014
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
H G Nguyen, J C Yang, H-J Kung, et al.
Surgical Endoscopy
|
June 17, 2005
Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis
C- H Chen, M- H Huang, J- C Yang, et al.
Animal Biotechnology
|
December 22, 2009
A single nucleotide polymorphism and sequence analysis of CSN1S1 gene promoter region in Chinese Bos grunniens (yak)
W L Bai, R H Yin, Q L Dou, et al.
JAMA
|
March 23, 1994
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
S A Rosenberg, J C Yang, S L Topalian, et al.
Cancer
|
August 15, 1995
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL-2
J C Yang, S L Topalian, D J Schwartzentruber, et al.
Nano Letters
|
September 22, 2012
Domain wall geometry controls conduction in ferroelectrics
R K Vasudevan, A N Morozovska, E A Eliseev, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 305) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies
J Weber, J C Yang, S L Topalian, et al.
Journal of Environmental Radioactivity
|
May 22, 2012
Inorganic phosphorus fractionation and its translocation dynamics in a low-P soil
J C Yang, Z G Wang, J Zhou, et al.
The New England Journal of Medicine
|
August 30, 1990
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
S A Rosenberg, P Aebersold, K Cornetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer
S A Rosenberg, M T Lotze, J C Yang, et al.
Oncogene
|
March 26, 2014
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
H G Nguyen, J C Yang, H-J Kung, et al.
Surgical Endoscopy
|
June 17, 2005
Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis
C- H Chen, M- H Huang, J- C Yang, et al.
Animal Biotechnology
|
December 22, 2009
A single nucleotide polymorphism and sequence analysis of CSN1S1 gene promoter region in Chinese Bos grunniens (yak)
W L Bai, R H Yin, Q L Dou, et al.
JAMA
|
March 23, 1994
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
S A Rosenberg, J C Yang, S L Topalian, et al.
Cancer
|
August 15, 1995
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL-2
J C Yang, S L Topalian, D J Schwartzentruber, et al.
Nano Letters
|
September 22, 2012
Domain wall geometry controls conduction in ferroelectrics
R K Vasudevan, A N Morozovska, E A Eliseev, et al.
Page
of 31